Zimmer Biomet Holdings, Inc. (ZBH) Earnings History
Profitable27 years of earnings data (1999–2025) · Positive TTM net income
Loading earnings history...
Zimmer Biomet Holdings, Inc. (ZBH) Earnings Overview
As of June 22, 2026, Zimmer Biomet Holdings, Inc. (ZBH) reported trailing twelve-month net income of $761M, reflecting -19.9% year-over-year growth. The company earned $3.89 per diluted share over the past four quarters, with a net profit margin of 8.6%.
Looking at the long-term picture, ZBH's historical earnings data spans multiple years. The company achieved its highest annual net income of $1.81B in fiscal 2017.
Zimmer Biomet Holdings, Inc. maintains positive profitability with a gross margin of 61.6%, operating margin of 16.5%, and net margin of 8.6%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including SYK ($3.25B net income, 12.9% margin), BSX ($2.89B net income, 14.4% margin), MDT ($4.61B net income, 13.9% margin), ZBH has room to improve margins relative to the peer group. Compare ZBH vs SYK →
ZBH Earnings vs Peers
Earnings metrics vs comparable public companies
ZBH Historical Earnings Data (1999–2025)
27 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $705M | -22.0% | $1.36B | $3.55 | 8.6% | 16.5% |
| 2024 | $904M | -11.7% | $1.29B | $4.43 | 11.8% | 16.7% |
| 2023 | $1.02B | +342.5% | $1.28B | $4.88 | 13.8% | 17.3% |
| 2022 | $231M | -42.4% | $696M | $1.10 | 3.3% | 10.0% |
| 2021 | $402M | +389.1% | $860M | $1.91 | 5.9% | 12.6% |
| 2020 | -$139M | -112.3% | $83M | $-0.67 | -2.3% | 1.4% |
| 2019 | $1.13B | +398.4% | $1.14B | $5.47 | 14.2% | 14.3% |
| 2018 | -$379M | -120.9% | $34M | $-1.86 | -4.8% | 0.4% |
| 2017 | $1.81B | +492.9% | $799M | $9.03 | 23.2% | 10.2% |
| 2016 | $306M | +108.1% | $821M | $1.50 | 4.0% | 10.7% |
| 2015 | $147M | -79.6% | $467M | $0.26 | 2.5% | 7.8% |
| 2014 | $720M | -5.3% | $1.04B | $4.19 | 15.4% | 22.2% |
| 2013 | $761M | +0.8% | $1.04B | $4.43 | 16.5% | 22.4% |
| 2012 | $755M | -0.8% | $1.05B | $4.29 | 16.9% | 23.4% |
| 2011 | $761M | +27.5% | $1.02B | $4.03 | 17.1% | 23.0% |
| 2010 | $597M | -16.8% | $917M | $2.97 | 14.1% | 21.7% |
| 2009 | $717M | -15.5% | $1.02B | $3.32 | 17.5% | 24.9% |
| 2008 | $849M | +9.8% | $1.09B | $3.72 | 20.6% | 26.4% |
| 2007 | $773M | -7.3% | $1.13B | $3.26 | 19.8% | 28.9% |
| 2006 | $835M | +13.9% | $1.17B | $3.40 | 23.9% | 33.3% |
| 2005 | $733M | +35.2% | $1.05B | $2.93 | 22.3% | 32.1% |
| 2004 | $542M | +56.5% | $763M | $2.19 | 18.2% | 25.6% |
| 2003 | $346M | +34.3% | $451M | $1.64 | 18.2% | 23.7% |
| 2002 | $258M | +72.1% | $401M | $1.31 | 18.8% | 29.2% |
| 2001 | $150M | -14.9% | $248M | $0.77 | 12.7% | 21.1% |
| 2000 | $176M | +17.3% | $268M | $0.91 | 16.9% | 25.8% |
| 1999 | $150M | - | $231M | $0.77 | 16.0% | 24.6% |
Download Data
Export ZBH earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into ZBH consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
27+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ZBH — Frequently Asked Questions
Quick answers to the most common questions about buying ZBH stock.
What is ZBH earnings per share (EPS)?
ZBH trailing twelve-month (TTM) diluted EPS is $3.89, reflecting -19.9% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 1999 to 2025 is available in the table on this page.
What is Zimmer Biomet Holdings, Inc.'s net income?
Zimmer Biomet Holdings, Inc. (ZBH) trailing twelve-month net income is $761M as of 2025. Earnings declined -19.9% year-over-year. Zimmer Biomet Holdings, Inc. has been profitable for 5 consecutive years.
Is ZBH profitable?
Yes, ZBH is profitable with a TTM net income of $761M and a net profit margin of +8.6%. Zimmer Biomet Holdings, Inc. has generated profits for 5 consecutive years.
What is ZBH's earnings growth rate?
ZBH compound annual EPS growth rates (CAGR): 1-Year: -19.9%, 3-Year: +47.8%, 5-Year: N/A, 10-Year: +29.9%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1999 to 2025.
What are ZBH's profit margins?
Zimmer Biomet Holdings, Inc. net profit margin is +8.6%, operating margin is +16.5%, and gross margin is +61.6%. Margins are within a typical range for the sector. Return on Equity is +5.6%.
Is ZBH growing earnings?
ZBH earnings are declining — EPS fell -19.9% year-over-year. TTM net income dropped to $761M. This contrasts with the 5-year CAGR of N/A.
What was ZBH's best earnings year?
Zimmer Biomet Holdings, Inc.'s highest annual net income on record is $1.8B, achieved in fiscal year 2017. Earnings history on this page spans 1999 to 2025 and includes all annual and quarterly figures.
What were ZBH's earnings last quarter?
ZBH's most recent reported quarter was Q1 2026. Net income was $238M with diluted EPS of $1.22. For a full breakdown of all quarters, see the quarterly earnings table on this page.